The European Medicines Agency (EMA) has approved AstraZeneca Covid-19 vaccine for use in the EU. The final decision on the use of this vaccine in the EU member states must be made by the European Commission. It is reported by DW.
The vaccine from AstraZeneca is the third drug approved for use in the EU. Prior to that, the EU allowed the use of vaccines by the German company BioNTech and its American partner Pfizer, as well as a drug from the Moderna concern.
According to experts, the AstraZeneca vaccine is cheaper than the other two manufacturers and has simple storage conditions. At the same time, there is insufficient data on the effectiveness of this vaccine for people over 65 years of age.
The Standing Committee on Vaccination (STIKO) at Germany's Robert Koch Institute (RKI) has already stated that the AstraZeneca vaccine should only be used for people between the ages of 18 and 64.
Earlier, AstraZeneca CEO Pascal Soriot supported the efforts of the company on vaccine production amid the tension with the EU states due to the delays in the vaccine supplies.
Soriot stated his team works ‘24/7 to fix the very many issues of production of the vaccine’.
He stated that the production of the drug is two months behind the rates planned by the company. Moreover, the late decision of the EU to sign contracts has restricted time for the elimination of issues with supplies.